Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Opportunities and barriers in omics-based biomarker discovery for steatotic liver diseases

28 Mar 2024

Abstract excerpt

The rising prevalence of liver diseases related to obesity and excessive use of alcohol is fuelling an increasing demand for accurate biomarkers aimed at community screening, diagnosis of steatohepatitis and significant fibrosis, monitoring, prognostication and prediction of treatment efficacy. Breakthroughs in omics methodologies and the power of bioinformatics have created an excellent opportunity to apply...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Endoplasmic Reticulum Stress and Disease
Share to Liver Disease Diagnosis and Treatment
Share to Pancreatic function and diabetes

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 38552880
DOI: 10.1016/j.jhep.2024.03.035

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Opportunities and barriers in omics-based biomarker discovery for steatotic liver diseasesPMID 38552880Read ↗

Unraveling MASLD Through the Use of Omics TechnologiesSemantic proximity Read ↗

Defining NASH from a Multi-Omics Systems Biology PerspectiveSemantic proximity Read ↗

Multiomics biomarkers for the prediction of nonalcoholic fatty liver disease severitySemantic proximity Read ↗

Interrogating mechanisms of liver fibrosis with omics.Semantic proximity Read ↗

Advances in multi-omics research on viral hepatitisSemantic proximity Read ↗

Support of precision medicine through risk-stratification in autoimmune liver diseases - histology, scoring systems, and non-invasive markers.Semantic proximity Read ↗

Genomics and proteomics in liver fibrosis and cirrhosisSemantic proximity Read ↗

A blood-based biomarker panel for non-invasive diagnosis of metabolic dysfunction-associated steatohepatitisSemantic proximity Read ↗

PSC Scientific Community Resource The PSC Scientific Community Resource: An Asset for Multi-Omics Interrogation of Primary Sclerosing CholangitisSemantic proximity Read ↗

Mass Spectrometry-Based Techniques Towards OMICS 2.0Semantic proximity Read ↗

Biomarkers of NAFLD progression: a lipidomics approach to an epidemic.Semantic proximity Read ↗

Evaluation of MARC1 Variants and Extracellular Vesicle Cytokeratin-18 as Predictive Biomarkers in a group of Egyptian MASLD and MASH patientsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.